The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study
Abstract
✓ The authors tested the hypothesis that proton magnetic resonance spectroscopy (1 H-MRS) imaging can be used as a supportive diagnostic tool to differentiate clinically stable brain tumors from those progressing as a result of low- to high-grade malignant transformation or posttherapeutic recurrence. Twenty-seven patients with cerebral gliomas verified on histological examination were studied repeatedly with 1 H-MRS imaging over a period of 3.5 years. At the time of each 1 H-MRS imaging study, clinical examination, MR imaging, positron emission tomography with 18 F-fluorodeoxyglucose, and biopsy findings (when available) were used to categorize each patient as having either stable or progressive disease. Measures of the percentage changes in the choline (Cho) 1 H-MRS imaging signal intensity between studies, which were obtained without knowledge of the clinical categorization, allowed the investigators to segregate the groups with a high degree of statistical significance. All progressive cases showed a Cho signal increase between studies of more than 45%, whereas all stable cases showed an elevation of less than 35%, no change, or even a decreased signal. The authors conclude that increased Cho levels coincide with malignant degeneration of cerebral gliomas and therefore may possibly be used as a supportive indicator of progression of these neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Response criteria for phase II studies of supratentorial malignant glioma.
Macdonald, D. R., Cascino, T. L., Schold, S. C., & Cairncross, J. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1277 · Cited by 2,409
Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
Urenjak, J., Williams, Sr., Gadian, D., & Noble, M. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-03-00981.1993 · Cited by 995
Di Chiro, G., DeLaPaz, R. L., Brooks, R. A., Sokoloff, L., Kornblith, P. L., Smith, B. H., Patronas, N. J., Kufta, C. V., Kessler, R. M., Johnston, G. S., et al. (1982) · Neurology · doi:10.1212/wnl.32.12.1323 · Cited by 752
A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline
Miller, B. L. (1991) · NMR in Biomedicine · doi:10.1002/nbm.1940040203 · Cited by 654
Preul, M. C., Caramanos, Z., Collins, D. L., Villemure, J.-G., Leblanc, R., Olivier, A., Pokrupa, R., & Arnold, D. L. (1996) · Nature Medicine · doi:10.1038/nm0396-323 · Cited by 523
Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres
Laws, E. R., Taylor, W. F., Clifton, M. B., & Okazaki, H. (1984) · Journal of Neurosurgery · doi:10.3171/jns.1984.61.4.0665 · Cited by 512
Chiro, G. D. (1987) · Investigative Radiology · doi:10.1097/00004424-198705000-00002 · Cited by 442
Self-citationDi Chiro, G., Oldfield, E., Wright, D., De Michele, D., Katz, D., Patronas, N., Doppman, J., Larson, S., Ito, M., & Kufta, C. (1988) · American Journal of Roentgenology · doi:10.2214/ajr.150.1.189 · Cited by 422
Prediction of survival in glioma patients by means of positron emission tomography
Patronas, N. J., Chiro, G. D., Kufta, C., Bairamian, D., Kornblith, P. L., Simon, R., & Larson, S. M. (1985) · Journal of Neurosurgery · doi:10.3171/jns.1985.62.6.0816 · Cited by 405
Self-citationBruhn, H., Frahm, J., Gyngell, M. L., Merboldt, K. D., Hänicke, W., Sauter, R., & Hamburger, C. (1989) · Radiology · doi:10.1148/radiology.172.2.2748837 · Cited by 397
Positron emission tomography in patients with glioma a predictor of prognosis
Alavi, J. Β., Alavi, A., Chawluk, J. B., Kushner, M., Powe, J., Hickey, W. F., & Reivich, M. (1988) · Cancer · Cited by 373
In vivo 1H MRS choline: Correlation with in vitro chemistry/histology
Miller, B. L., Changl, L., Booth, R., Ernst, T., Cornford, M., Nikas, D., McBride, D., & Jenden, D. J. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00182-8 · Cited by 367
Multisection proton MR spectroscopic imaging of the brain.
Duyn, J. H., Gillen, J., Sobering, G., van Zijl, P. C., & Moonen, C. T. (1993) · Radiology · doi:10.1148/radiology.188.1.8511313 · Cited by 356
Self-citationProton MR Spectroscopy of Intracranial Tumours: In Vivo and In Vitro Studies
Gill, S. S., Thomas, D. G. T., Bruggen, N. V., Gadian, D. G., Peden, C. J., Bell, J. D., Cox, I. J., Menon, D. K., Iles, R. A., Bryant, D. J., et al. (1990) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199007000-00001 · Cited by 307
Patronas, N. J., Di Chiro, G., Brooks, R. A., DeLaPaz, R. L., Kornblith, P. L., Smith, B. H., Rizzoli, H. V., Kessler, R. M., Manning, R. G., Channing, M., et al. (1982) · Radiology · doi:10.1148/radiology.144.4.6981123 · Cited by 298
Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani, H., Rk, G., Roy, R., Pandey, R., Jain, V., & Chhabra, D. K. (1995) · PubMed · Cited by 289
[Clinical applications of magnetic resonance spectroscopy].
Terrier, F., Vock, P., HERSCHKOWITZ, N. N., Lazeyras, F., & Aue, W. P. (1988) · PubMed · Cited by 239
Valk, P. E., Budinger, T. F., Levin, V. A., Silver, P., Gutin, P. H., & Doyle, W. K. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.69.6.0830 · Cited by 218
Observations on the current treatment of low-grade astrocytic tumors of the cerebral hemispheres
Piepmeier, J. M. (1987) · Journal of Neurosurgery · doi:10.3171/jns.1987.67.2.0177 · Cited by 208
Quantitative proton spectroscopy of canine brain: in Vivo and in Vitro correlations
Barker, P. B., Breiter, S. N., Soher, B. J., Chatham, J. C., Forder, J. R., Samphilipo, M. A., Magee, C. A., & Anderson, J. H. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910320202 · Cited by 187
Correlation of glucose consumption and tumor cell density in astrocytomas
Herholz, K., Pietrzyk, U., Voges, J., Schröder, R., Halber, M., Treuer, H., Sturm, V., & Heiss, W. (1993) · Journal of neurosurgery · doi:10.3171/jns.1993.79.6.0853 · Cited by 144
In vivo imaging of glucose consumption and lactate concentration in human gliomas
Herholz, K., Heindel, W. L., Luyten, P. R., denHollander, J. A., Pietrzyk, U., Voges, J., Kugel, H., Friedmann, G., & Heiss, W. (1992) · Annals of Neurology · doi:10.1002/ana.410310315 · Cited by 125
Moffett, J. R., Namboodiri, M., & Neale, J. (1993) · Journal of Histochemistry and Cytochemistry · doi:10.1177/41.4.8450195 · Cited by 125
Diseases of the nervous system: Clinical neurobiology
STARK, G. D. (1992) · Neuromuscular Disorders · doi:10.1016/0960-8966(92)90013-v · Cited by 117
Tedeschi, G., Bertolino, A., Righini, A., Campbell, G., Raman, R., Duyn, J. H., MOONEN, C. T. W., Alger, J. R., & Chiro, G. D. (1995) · Neurology · doi:10.1212/wnl.45.7.1384 · Cited by 103
Self-citationFDG-PET as a Prognostic Indicator in Radiochemotherapy of Glioblastoma
Hölzer, T., Herholz, K., Jeske, J., & Heiss, W. (1993) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199309000-00002 · Cited by 98
FDG-PET in the Selection of Brain Lesions for Biopsy
Hanson, M. W., Glantz, M., Hoffman, J. M., Friedman, A. H., Burger, P. C., Schold, S. C., & Coleman, R. E. (1991) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199109000-00013 · Cited by 97
Reproducibility of proton MR spectroscopic imaging findings.
Tedeschi, G., Bertolino, A., Campbell, G., Barnett, A. S., Duyn, J. H., Jacob, P. K., MOONEN, C. T. W., Alger, J. R., & Chiro, G. D. (1997) · PubMed · Cited by 55
Self-citationWhat the clinician can learn from MRS lactate measurements
Prichard, J. W. (1991) · NMR in Biomedicine · doi:10.1002/nbm.1940040212 · Cited by 49
Fields, W. S. (1989) · Springer eBooks · doi:10.1007/978-1-4612-3676-4 · Cited by 34
Cited by
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality
Ling, C. C., Humm, J., Larson, S., Amols, H., Fuks, Z., Leibel, S., & Koutcher, J. A. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00467-3 · Cited by 926
Fass, L. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.04.001 · Cited by 822
Duffau, H. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70140-x · Cited by 683
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications
Soares, D. P., & Law, M. (2009) · Clinical Radiology · doi:10.1016/j.crad.2008.07.002 · Cited by 459
Active targeting of brain tumors using nanocarriers
Béduneau, A., Saulnier, P., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.06.011 · Cited by 424
Metadata
- Authors
- Tedeschi, G., Lundbom, N., Raman, R., Bonavita, S., Duyn, J. H., Alger, J. R., & Chiro, G. D.
- Venue
- Journal of Neurosurgery
- Published
- 1997-10
- Volume
- 87
- Issue
- 4
- Pages
- 516-524
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2169389408
- Cited by
- 268
- References
- 30
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.